Company Filing History:
Years Active: 2025
Title: Innovations in Biomedicine by Yujuan Hua
Introduction
Yujuan Hua is a notable inventor based in Suzhou, China. He has made significant contributions to the field of biomedicine, particularly in the development of vaccines and therapeutic agents. His work focuses on improving the stability and immunogenicity of viral proteins, which is crucial for effective vaccine development.
Latest Patents
Yujuan Hua holds a patent for "Mutants of respiratory syncytial virus fusion proteins." This patent relates to an improved mutant of the respiratory syncytial virus (RSV) fusion (F) protein. The innovation allows the mutant to form a trimeric structure without the need for a heterologous trimerization domain. Through various mutation designs, such as releasing internal electrostatic repulsion and deleting the furin cleavage site, the protein is stabilized in its pre-fusion conformation. This enhancement leads to increased stability and immunogenicity, making it a promising candidate for vaccine development against RSV infection.
Career Highlights
Yujuan Hua is associated with Yikang Biotech (Suzhou) Co., Ltd., where he continues to advance his research in biomedicine. His work has the potential to significantly impact public health by providing effective solutions for RSV infections.
Collaborations
Yujuan collaborates with talented individuals in his field, including Lei Chen and Yujiao Song. Their combined expertise contributes to the innovative research and development efforts at Yikang Biotech.
Conclusion
Yujuan Hua's contributions to biomedicine, particularly through his patent on RSV fusion proteins, highlight the importance of innovation in vaccine development. His work not only enhances our understanding of viral proteins but also paves the way for effective treatments against respiratory infections.